Edcetera expands its footprint in engineering education with the acquisition of exam prep solution PrepFE
WAUKESHA, Wis., Sept. 15, 2022 /PRNewswire/ — Edcetera, the Eden Capital-backed provider of continuing education, exam prep, and licensing programs, today announced the acquisition of PrepFE, an exam prep platform that helps engineers pass the Fundamentals of Engineering (FE) exam to become Engineers-in-Training (EIT), which is a required step for aspiring Professional Engineers (PE). The acquisition continues the company’s rapid expansion into the engineering education, training, and licensure market following its acquisition of continuing education provider SunCam earlier this year.
“With the global demand for engineers higher than ever, professional licensure can offer a pathway to greater earning power, growth potential, and autonomy for those just starting a career path in engineering,” said Nader Qaimari, chief executive officer of Edcetera. “Built by engineers for engineers, PrepFE delivers a comprehensive, intuitive, and–most importantly–effective exam prep experience for engineers as they take their first critical step toward the PE license.”
According to the Bureau of Labor Statistics, there are more than 1.6 million engineers in the workforce—a number expected to grow 7% over the next 10 years, with an even faster rate of growth in fields such as civil and mechanical engineering where licensure is often required to sign and seal engineering plans that are submitted to public sector agencies or clients.
Since its founding by a team of engineers in 2017, PrepFE has emerged as one of the most popular providers of exam prep courses for the FE exam. The company’s research-driven exam prep system provides students with comprehensive sample test questions along with tips and detailed explanations to help them improve their score. PrepFE courses currently help aspiring EITs pass exams for civil engineering, mechanical engineering, electrical and computer engineering, chemical engineering, and other disciplines.
“We focused on creating an exam prep experience that harnesses the power of active learning to help engineers practice, refine their problem-solving skills, and build their confidence as they prepare,” said Damien Sutevski, founder of PrepFE. “We’ve been incredibly gratified to hear from so many early career engineers that we succeeded. We look forward to working with the Edcetera team to help even more engineers pass the FE exam and, in the near future, pass the PE exam as well.”
PrepFE is led by a team of subject matter experts—with experience at SpaceX, AECOM, Disney and Nantworks—who themselves hold masters and doctorates in their respective fields and have professional experience across mechanical, aerospace, civil, electrical engineering, and computer science disciplines.
The acquisition will enable PrepFE to fuel investments in product innovation and the creation of new educational offerings designed to meet the needs of engineers throughout their career. Edcetera now has educational offerings in engineering covering the entire professional lifecycle from career entry and exam prep to continuing education and professional development.
Best known for creating widely used continuing education courses for licensed professionals and exam preparation in engineering, architecture, and the skilled trades, Edcetera has evolved to become an end-to-end provider of training and education in health care, skilled trades, and licensed professions. “With the PrepFE acquisition, Edcetera is deepening its commitment and offering to support engineering professionals throughout their career,” explained Dina Said, managing partner at Eden Capital.
To learn more about the company’s suite of flexible programming created to advance workers’ career pursuits, visit www.edcet.com.
About Edcetera: Edcetera is on a mission to help unlock opportunity by harnessing the power of credentialing and professional licensure. We help people at all stages of their careers by providing licensing, test preparation, and continuing education. Our significant regulatory experience, paired with our extensive breadth of subject matter expertise and agile delivery methods allow us to adapt rapidly to new and evolving regulatory and professional requirements and trends in health care, skilled trades, and licensed professions.
About PrepFE: At the heart of PrepFE is a team of engineers who decided to build a new best-in-class product after learning the hard way that FE exam prep materials available at the time were poor quality, inconvenient, and costly. The result is an intuitive, affordable, and effective prep course that has helped thousands of aspiring PEs pass the FE exam.
View original content:https://www.prnewswire.com/news-releases/online-education-pioneer-acquires-popular-exam-prep-provider-for-engineers-in-training-301625324.html
After enjoying a brief rally late last week on hopes that China's rolled-back zero-COVID policies might allow its economy to grow a bit faster — and permit Tesla (NASDAQ: TSLA) to produce a few more electric cars there as supply chains unsnarl — Tesla stock hit a bump in the road today. The reason is a poll released by the international research data and analytics group YouGov. According to YouGov, Tesla is one of the most famous brands in the world today, with an astounding 97% of Americans surveyed having heard of Elon Musk's pioneering electric car company.
Toyota is known for a lot of different things, mainly automobiles, but the company also makes sewing machines, forklifts, robotics, boats and even houses. Of course, the main line of business Toyota handles is automobiles. While being a true leader in the automobile industry, Toyota has dealt with its own setbacks.
Is there more pain ahead?
Brookfield Asset Management (NYSE: BAM) recently completed a unique stock split. Brookfield completed this split so that its investors would have direct exposure to its asset management business's dividend income and growth. CEO Bruce Flatt recently discussed the growth it has already locked up at a recent industry conference.
In this article, we will take a look at the 10 cheap small-cap stocks to buy before the next breakout. If you want to see more stocks in this selection, go to the 5 Cheap Small-Cap Stocks to Buy Before the Next Breakout. Some of the prominent large and mega-cap stocks in the world today used […]
Two top-tier chipmakers stand out as screaming buys for the new year, while another widely held semiconductor stock is facing a mountain of headwinds.
It's an announcement that is somewhat like a thunderbolt in the automotive industry. Three months ago, Rivian, which aims to challenge Tesla in the race for electric vehicles, announced with fanfare a partnership with Mercedes-Benz to manufacture electric vans in Europe. For Rivian , it was a key partnership as the company encountered difficulties in increasing its production capacities.
H.C. Wainwright initiated coverage on Affimed NV (NASDAQ: AFMD), a clinical-stage biotechnology company focused on developing innate cell engagers (ICEs) for cancer treatment. The analyst has a Buy rating with a price target of $6 and says that ICEs have promising potential in cancer treatment, given their superior CD16A binding profile and unique mechanisms of action. Affimed's lead clinical candidate, AFM13, an anti-CD30 ICE, has demonstrated a manageable tolerability profile and promising cli
If you're looking for alternative ways, outside of the stock market and bonds, to create retirement income, an annuity could be right for you. Whether you're nearing retirement age or have decades to go, a $500,000 annuity can provide consistent, … Continue reading → The post How Much Does a $500K Annuity Pay Per Month? appeared first on SmartAsset Blog.
The FDA grants fast-track designation to Pfizer (PFE)/BioNTech's (BNTX) early-stage combination vaccine candidate, which targets two respiratory diseases – influenza and COVID-19.
Early retirement is a dream for many — that can turn into a nightmare.
Yahoo Finance Live anchors discuss the rise in stock for Coupa following Thoma Bravo’s $8 billion acquisition.
Harpoon Therapeutics Inc (NASDAQ: HARP) presented updated interim data from its Phase 1 trial evaluating single-agent HPN217 in relapsed/refractory multiple myeloma (RRMM) at the American Society of Hematology (ASH) Annual Meeting and Exposition. As of the data cut-off date of October 17, the interim results showed that HPN217 demonstrated clinical activity and a tolerable safety profile in heavily pre-treated patients with RRMM (62 patients treated across fixed dose and step dose regimens). HPN
While some of these tech stocks were riding the tide and will never see new highs, others have been unfairly thrown out with the rest and could eventually comeback for a rebound. Bold investors can consider these tech stocks as speculative holdings in a diversified portfolio. Fintech company Upstart Holdings (NASDAQ: UPST) uses artificial intelligence to determine creditworthiness instead of a traditional credit score.
ExxonMobil (NYSE: XOM) shares closed out last week on a down note, as investors digested the details of the oil giant's latest "five-year plan": paying down debt, buying back stock, and allowing profits and cash flow to fall well below 2022 levels. You can thank the oil market for that. Oil prices popped Monday morning, with the cost of a barrel of WTI crude up 3.4% at $73.40 and Brent crude, the international benchmark, rising 2.8% to $78.19.
As FTX continues to be unwound, its new CEO is set to tell Congress at least five things he knows the company did with the money from clients and investors.
Shares of Nvidia (NASDAQ: NVDA) are down 43% since the start of 2022. The company has struggled to offload its backlog of 3000 series graphics cards, and reaction to its new 4000 series has been tepid at best. The response to its newly released RTX 4090 and RTX 4080 graphics cards is a potential disaster for the company, as 59% of Nvidia's revenue comes from its Graphics segment.
Even if you believe you're set, the money guru says too often people retire with only enough savings to last a few years.
GE HealthCare management is meeting with investors before it separates from General Electric in early January.
In this article, we will discuss the 13 best blockchain stocks to buy now. If you want to skip our analysis of the blockchain industry and explore similar stocks, you can also take a look at 5 Best Blockchain Stocks To Buy Now. Blockchain is a revolutionary technology that is gaining rapid popularity among various industries. […]
Edcetera expands its footprint in engineering education with the acquisition of exam prep solution PrepFE